Germany Cattle Vaccines Market Insight
Published: 21 May 2026 | Report Format: Electronic (PDF)
High emphasis on herd lifestyle, antibiotic usage, and sustainable dairy and beef outputs leads to long term opportunities for multivalent vaccines for cattle that improvise disease defense, performance, and farm profitability.
Germany Cattle Vaccines Market Insights and Forecasts to 2035
- In 2025, the Germany Cattle Vaccines Market stood at USD 137.4 Million, establishing a strong base for future growth.
- It is anticipated to expand at a CAGR of 6.2% over 2025 to 2035, supported by preventive immunization trend.
- The market is projected to reach USD 250.7 Million by 2035, reflecting continuous long-term growth.
Notable Insights for the Germany Cattle Vaccines Market
- By vaccine type, inactivated (Killed) vaccines dominate the market by 52-54% share. The reason is they offer excellent safety, stability, and compatibility with Germany’s highly regulated livestock vaccination initiatives.
- By indication, bovine respiratory disease (BRD) vaccines dominate the market by 34-36% share. BRD vaccines lead due to the economic benefits of respiratory infections on milk yield, weight gain, and veterinary expenses.
- Boehringer Ingelheim put about €6.2 billion (roughly USD 6.7 billion) into R&D during 2024, and remarkable share of it dedicated toward animal health, and livestock biologics development.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Germany cattle vaccines market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Germany Cattle Vaccines Market
- Boehringer Ingelheim
- Bayer AG
- MSD Animal Health
- Zoetis
- HIPRA
- Ceva Sante Animale
- Elanco Animal Health
- Virbac
- Vetoquinol
- Bioveta
Recent Developments:
- In April 2025, Boehringer Ingelheim reached record spending in R&D of €6.2 billion and, pointed at a continued widening of its livestock vaccine range, with solutions that focus on cattle disease prevention.
- In October 2024, HIPRA then strengthened distribution, of its bovine vaccines across major European livestock markets. This includes Germany. The goal is to support respiratory and reproductive disease control in cattle to stay them healthier.
Market Segmentation:
Germany Cattle Vaccines Market, By Vaccine Type
- Live Attenuated Vaccines
- Inactivated (Killed) Vaccines
- Recombinant and Subunit Vaccines
Germany Cattle Vaccines Market, By Disease Indication
- Bovine Respiratory Disease (BRD)
- Bovine Viral Diarrhea (BVD)
- Clostridial Diseases
Germany Cattle Vaccines Market, By End User
- Dairy Farms
- Beef Cattle Farms
- Veterinary Clinics and Cooperatives
Expert Views:
Growth is being witnessed in Germany’s vaccines for cattle market owing to the prioritization of preventive healthcare practices by farmers. The high commitment of Boehringer Ingelheim towards innovations in animal health will sustain the market growth in the years ahead.
Author: Komal and Radhika By Spherical Insights and Consulting